Christopher Stroh
Impact in
- Oncology top 0.5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 23
- Colorectal Cancer Treatments and Studies 10
- Lung Cancer Research Studies 5
- PARP inhibition in cancer therapy 3
-
- Lung Cancer Treatments and Mutations 20
- Co-authors
- Klaus Schulze‐Osthoff (13 shared papers)Anatoly Makhson (2 shared papers)Eric Van Cutsem (5 shared papers)Sabine Tejpar (7 shared papers)Philippe Rougier (2 shared papers)Claus-Henning Köhne (2 shared papers)Jerzy Załuski (2 shared papers)Gunnar Folprecht (2 shared papers)
- Journals
- Annals of Oncology (7 papers)Oncogene (4 papers)Journal of Clinical Oncology (4 papers)Cell Death and Differentiation (3 papers)Clinical Cancer Research (3 papers)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Christopher Stroh
53 papers receiving 8.3k citations
Christopher Stroh's Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 4.8k
- Hepatology 1.1k
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 2.0k
- Pathology and Forensic Medicine 1.1k
Countries citing papers authored by Christopher Stroh
This map shows the geographic impact of Christopher Stroh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Stroh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Stroh more than expected).
Fields of papers citing papers by Christopher Stroh
This network shows the impact of papers produced by Christopher Stroh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Stroh. The network helps show where Christopher Stroh may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Stroh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer Hit paper breakdown → | 2009 | 3200 |
| 2 | Fluorouracil, Leucovorin, and Oxaliplatin With and Without Cetuximab in the First-Line Treatment of Metastatic Colorectal Cancer Hit paper breakdown → | 2008 | 1355 |
| 3 | Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer Hit paper breakdown → | 2015 | 671 |
| 4 | Tepotinib in Non–Small-Cell Lung Cancer with MET Exon 14 Skipping Mutations Hit paper breakdown → | 2020 | 658 |
| 5 | 2002 | 439 | |
| 6 | 1998 | 245 | |
| 7 | 2000 | 236 | |
| 8 | 2010 | 199 | |
| 9 | 2001 | 154 | |
| 10 | 1999 | 141 | |
| 11 | 2005 | 116 | |
| 12 | 2003 | 103 | |
| 13 | 2002 | 97 | |
| 14 | 2010 | 95 | |
| 15 | 2005 | 83 | |
| 16 | 2009 | 78 | |
| 17 | 1994 | 73 | |
| 18 | Tepotinib plus osimertinib in patients with EGFR-mutated non-small-cell lung cancer with MET amplification following progression on first-line osimertinib (INSIGHT 2): a multicentre, open-label, phase 2 trial Hit paper breakdown → | 2024 | 64 |
| 19 | 2020 | 60 | |
| 20 | 2016 | 60 |
About Christopher Stroh
Christopher Stroh is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Cancer Research and Molecular Biology, having authored 54 papers that have together received 8.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (20 papers), Colorectal Cancer Treatments and Studies (10 papers), Cell death mechanisms and regulation (8 papers), Liver physiology and pathology (6 papers), Lung Cancer Research Studies (5 papers), Cancer Genomics and Diagnostics (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and PARP inhibition in cancer therapy (3 papers). The work is most often cited by research in Oncology (4.8k citations), Hepatology (1.1k citations), Cancer Research (1.1k citations), Pulmonary and Respiratory Medicine (2.0k citations) and Pathology and Forensic Medicine (1.1k citations). Christopher Stroh has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Klaus Schulze‐Osthoff, Anatoly Makhson, Eric Van Cutsem, Sabine Tejpar, Philippe Rougier, Claus-Henning Köhne, Jerzy Załuski, Gunnar Folprecht, Jae Kyung Roh and Geert D’Haens. Their work appears in journals such as Annals of Oncology, Oncogene, Journal of Clinical Oncology, Cell Death and Differentiation and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.